Detalles de la búsqueda
1.
Belantamab Mafodotin, Bortezomib, and Dexamethasone for Multiple Myeloma.
N Engl J Med
; 2024 Jun 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-38828933
2.
Comparison of SOX2 and POU5F1 Gene Expression in Leukapheresis-Derived CD34+ Cells before and during Cell Culture.
Int J Mol Sci
; 24(4)2023 Feb 20.
Artículo
en Inglés
| MEDLINE | ID: mdl-36835597
3.
Chronic active Epstein-Barr virus infection as the basis of neoplasm development. Transformation of chronic lymphocytic leukaemia to NK-cell lymphoma/leukaemia was observed by flow cytometry - a diagnostic report.
Cent Eur J Immunol
; 48(3): 257-266, 2023.
Artículo
en Inglés
| MEDLINE | ID: mdl-37901865
4.
Predictive significance of selected gene mutations in relapsed and refractory chronic lymphocytic leukemia patients treated with ibrutinib.
Eur J Haematol
; 106(3): 320-326, 2021 Mar.
Artículo
en Inglés
| MEDLINE | ID: mdl-33190294
5.
Stem cell mobilization in multiple myeloma patients relapsing after previous autologous hematopoietic stem cell transplantation: A multicenter report by the Polish Myeloma Study Group.
J Clin Apher
; 36(3): 443-453, 2021 Jun.
Artículo
en Inglés
| MEDLINE | ID: mdl-33592119
6.
Serum brain-derived neurotrophic factor (BDNF) concentration predicts polyneuropathy and overall survival in multiple myeloma patients.
Br J Haematol
; 191(1): 77-89, 2020 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-32567687
7.
Prognostic value of pretreatment neutrophil-to-lymphocyte and platelet-to-lymphocyte ratios in multiple myeloma patients treated with thalidomide-based regimen.
Ann Hematol
; 99(12): 2881-2891, 2020 Dec.
Artículo
en Inglés
| MEDLINE | ID: mdl-32458064
8.
Polymorphisms in the promotor region of the CRBN gene as a predictive factor for peripheral neuropathy in the course of thalidomide-based chemotherapy in multiple myeloma patients.
Br J Haematol
; 186(5): 695-705, 2019 09.
Artículo
en Inglés
| MEDLINE | ID: mdl-31115923
9.
A phase III randomized, multicentre, double blind, active controlled trial to compare the efficacy and safety of two different anagrelide formulations in patients with essential thrombocythaemia - the TEAM-ET 2·0 trial.
Br J Haematol
; 185(4): 691-700, 2019 05.
Artículo
en Inglés
| MEDLINE | ID: mdl-30919941
10.
Age-dependent determinants of infectious complications profile in children and adults after hematopoietic cell transplantation: lesson from the nationwide study.
Ann Hematol
; 98(9): 2197-2211, 2019 Sep.
Artículo
en Inglés
| MEDLINE | ID: mdl-31321454
11.
Central nervous involvement by chronic lymphocytic leukaemia.
Neurol Neurochir Pol
; 52(2): 228-234, 2018 Mar.
Artículo
en Inglés
| MEDLINE | ID: mdl-29146406
12.
Intraventricular treatment of secondary central nervous system lymphoma - Case study and literature overview.
Neurol Neurochir Pol
; 52(3): 410-414, 2018.
Artículo
en Inglés
| MEDLINE | ID: mdl-29703403
13.
Specific cytotoxic T-cell immune responses against autoantigens recognized by chronic lymphocytic leukaemia cells.
Br J Haematol
; 174(4): 582-90, 2016 08.
Artículo
en Inglés
| MEDLINE | ID: mdl-27097566
14.
Danazol induces apoptosis and cytotoxicity of leukemic cells alone and in combination with purine nucleoside analogs in chronic lymphocytic leukemia.
Ann Hematol
; 95(3): 425-35, 2016 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-26692089
15.
New prognostic biomarkers in multiple myeloma.
Postepy Hig Med Dosw (Online)
; 70(0): 811-9, 2016 Jan 04.
Artículo
en Inglés
| MEDLINE | ID: mdl-27463592
16.
Therapy-related peripheral neuropathy in multiple myeloma patients.
Hematol Oncol
; 33(4): 113-9, 2015 Dec.
Artículo
en Inglés
| MEDLINE | ID: mdl-25399783
17.
The rate of in vitro fludarabine-induced peripheral blood and bone marrow cell apoptosis may predict the chemotherapy outcome in patients with chronic lymphocytic leukemia.
Eur J Clin Pharmacol
; 71(9): 1121-7, 2015 Sep.
Artículo
en Inglés
| MEDLINE | ID: mdl-26141594
18.
New drugs in multiple myeloma - role of carfilzomib and pomalidomide.
Contemp Oncol (Pozn)
; 18(1): 17-21, 2014.
Artículo
en Inglés
| MEDLINE | ID: mdl-24876816
19.
Predicting chemotherapy toxicity in multiple myeloma: the prognostic value of pre-treatment serum cytokine levels of interleukin-6, interleukin-8, monocyte chemoattractant protein-1, and vascular endothelial growth factor.
Front Immunol
; 15: 1377546, 2024.
Artículo
en Inglés
| MEDLINE | ID: mdl-38846938
20.
IL1B Polymorphism (rs1143634) and IL-1ß Plasma Concentration as Predictors of Nutritional Disorders and Prognostic Factors in Multiple Myeloma Patients.
Cancers (Basel)
; 16(7)2024 Mar 24.
Artículo
en Inglés
| MEDLINE | ID: mdl-38610941